UPDATE 1-FDA declines to approve Valeant's plaque psoriasis treatment
June 18, 2018 at 08:28 AM EDT
June 18 (Reuters) - Canada-based Valeant Pharmaceuticals International said on Monday that U.S. health regulators had declined to approve its lotion to treat plaque psoriasis, citing questions related to certain data.
